22nd Century Group, Inc. Stock price

Equities

XXII

US90137F2020

Tobacco

Market Closed - Nasdaq 04:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
0.1315 USD +0.08% Intraday chart for 22nd Century Group, Inc. -5.60% -29.38%
Sales 2023 * 81.91M Sales 2024 * 120M Capitalization 5.76M
Net income 2023 * -124M Net income 2024 * -32M EV / Sales 2023 * 0.07 x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * 0.05 x
P/E ratio 2023 *
-0.02 x
P/E ratio 2024 *
-0.08 x
Employees 198
Yield 2023 *
-
Yield 2024 *
-
Free-Float 98.68%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : 22nd Century Group, Inc. - Special Call
Specialty Acquisition Corporation completed the acquisition of Substantially all of GVB hemp/cannabis business from 22nd Century Group, Inc. and ESI Holdings, LLC for $3.1 million. CI
22Nd Century Group, Inc. Announces Termination of Peter Ferola as the Chief Legal Officer and Corporate Secretary CI
22nd Century Group Names Lawrence Firestone as Chair, Chief Executive MT
22Nd Century Group, Inc. Appoints Lawrence Firestone as Chief Executive Officer CI
22Nd Century Group, Inc. Appoints Lawrence Firestone as Chairman CI
22nd Century Group to Sell Hemp, Cannabis Business; Shares Rise After Hours MT
Specialty Acquisition Corporation entered into a equity purchase agreement to acquire Substantially all of GVB hemp/cannabis business from 22nd Century Group, Inc. and ESI Holdings, LLC for $2.3 million. CI
22nd Century Group, Inc. Continues VLN Expansion, Now Retailing in More Than 5,100 Stores CI
22nd Century Signs Additional Reduced Nicotine Content Technology License MT
22Nd Century Group, Inc. Expands Reduced Nicotine Content Tobacco IP with Latest Technology License CI
22Nd Century Remains 'Committed' to Exploring Wide Range of Alternatives CI
22nd Century Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (XXII) 22ND CENTURY GROUP Reports Q3 Revenue $17.8M MT
22Nd Century Group, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2023 CI
More news

Latest transcript on 22nd Century Group, Inc.

1 day+0.08%
1 week-5.60%
Current month-6.00%
1 month-6.74%
3 months-29.11%
6 months-85.58%
Current year-29.38%
More quotes
1 week
0.13
Extreme 0.1291
0.14
1 month
0.10
Extreme 0.1042
0.18
Current year
0.10
Extreme 0.1042
0.22
1 year
0.10
Extreme 0.1042
12.00
3 years
0.10
Extreme 0.1042
91.05
5 years
0.10
Extreme 0.1042
91.05
10 years
0.10
Extreme 0.1042
91.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 Nov. 27
Director of Finance/CFO 57 22-06-14
Chief Tech/Sci/R&D Officer - 22-05-22
Members of the board TitleAgeSince
Director/Board Member 77 22-09-11
Chief Executive Officer 66 Nov. 27
Director/Board Member 64 23-07-18
More insiders
Date Price Change Volume
24-03-27 0.1315 +0.08% 2,171,802
24-03-26 0.1314 +0.23% 1,192,377
24-03-25 0.1311 -3.60% 928,049
24-03-22 0.136 +5.43% 1,353,873
24-03-21 0.129 -7.39% 1,154,743

Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT

More quotes
22nd Century Group, Inc. is an agricultural biotechnology and intellectual property company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the consumer goods and pharmaceutical industries. The Company operates through two segments: Tobacco and Hemp/cannabis. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers’ branded filtered cigars and cigarettes. Its tobacco segment is engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. Its Hemp/cannabis segment is engaged in developing cannabidiol (CBD) wholesale extracts and bulk ingredient distillate or isolate.
Sector
Tobacco
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.1315
Average target price
-
Consensus
  1. Stock
  2. Equities
  3. Stock 22nd Century Group, Inc. - Nasdaq